Delivery Order V797D30296-VA24814F3466

The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc. The order is for 120 capsules of XTANDI 40 MG CAPSULE to be delivered to a location in Park Ridge, Illinois. XTANDI is used to treat men with prostate cancer. The period of performance for this order is from August 29, 2023 through August 30, 2023. No subcontractors or set aside designations were...

This delivery order, awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE. The potential value of this firm fixed price order is $4,311.35. Performance will occur in Park Ridge, Illinois with an anticipated completion date of October 6, 2023. No set-aside designation was used for this award placed under an unidentified medical supply vehicle. The Defense Logistics Agency Troop Support Medical...

This delivery order for $4,311.35, awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., is for 120 capsules of XTANDI 40 MG CAPSULE to be delivered by October 12, 2023. The firm fixed price contract has no set-aside designation. XTANDI is used to treat men with prostate cancer and this order will support the Defense Logistics Agency's medical supply needs. DMS Pharmaceutical Group Inc. will deliver the products from their facility in Park Ridge,...

This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE. The potential value of this firm fixed price order is $12,934.05. Performance will occur in Park Ridge, Illinois, with delivery required by May 30, 2023. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support for the U.S. military, this order is likely intended to...

The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at twenty-five thousand seventeen dollars and fifty-four cents ($25,017.54) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for one hundred twenty (120) tablets of XTANDI 40 MG to be delivered between September 11-12, 2023. XTANDI is used to treat prostate cancer and this order will support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside...

The Defense Logistics Agency Troop Support Medical awarded a $4,311 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 mg for prostate cancer treatment. The one-day contract has a period of performance from August 30 to August 31, 2023, with all products to be delivered from the contractor's facility in Park Ridge, Illinois. No set aside provisions or subcontractors were identified. This order is likely in support of the Defense Health Agency's...

This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the provision of 120 capsules of XTANDI 40 MG CAPSULE. The order has a potential value of $77,604.30 under a firm fixed price arrangement. Performance will occur in Park Ridge, Illinois with an anticipated completion date of October 16, 2023. No set-aside designation was applied to this award made in support of the Defense Logistics Agency's pharmaceutical procurement and distribution programs.

This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the provision of 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $8,643.02. The place of performance is Park Ridge, Illinois and all items are to be delivered by November 10, 2022. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement, distribution and supply chain management for the...

This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 8 to Astellas Pharma US, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the chemotherapy drug XTANDI (enzalutamide 40mg) and was awarded under the Pharmaceuticals and Drugs GSA Schedule. The contract has a ceiling value of $76,788.00 and a period of performance ending on September 30, 2015. There was no set-aside designation for this...

The Defense Logistics Agency awarded a $12,934.05 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 120 capsules of XTANDI 40 MG for prostate cancer treatment. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Park Ridge, Illinois from July 24-25, 2023. No subcontractors or set aside designations were identified. This order supports DLA's...